In a significant event organised by Eastern Eye (EE), a sister publication of Pharmacy Business, political leaders gathered on July 1st to address pressing
issues affecting the Asian community
The EE election debate aimed to amplify their political voice and encourage participation in the political process.
The debate, moderated by Barnie Choudhury, Editor of Eastern Eye, saw prominent figures including Andrew Boff AM of the Conservative Party, Anneliese Dodds
represented Labour as Shadow Secretary of State for Women and Equalities, and Lord Richard Newby from the Liberal Democrats engaged in a robust discussion.
They fielded questions on various issues affecting the UK, including economic and social inequality, immigration, health inequalities, and funding cuts to
community pharmacies.
Amid an audience that included stakeholders from the pharmacy sector, a notable query focused on each party's stance on the role of community pharmacies and
their commitment to funding these vital services.
Amid the rapid rise in semaglutide usage, a study has suggested a potential risk of a rare eye condition associated with the weight loss drug.
Semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is available under the brand name Ozempic (by Novo Nordisk) in a lower-dose form for managing
type 2 diabetes mellitus (T2DM), and as Wegovy (also by Novo Nordisk) in a higher-dose form for weight management in patients with high body mass indexes.
Anecdotal evidence has indicated that semaglutide might be linked to nonarteritic anterior ischemic optic neuropathy (NAION).
To investigate this potential connection, researchers in the United States analysed data over a six-year period from nearly 17,000 neuro-ophthalmology patients at
Massachusetts Eye and Ear Hospital in Boston, Massachusetts, all of whom had no prior history of NAION.
NHS England has confirmed the initial sites that will test and implement Martha's Rule in the first phase of the programme.
This follows the announcement in February regarding NHSE funding for the major patient safety initiative for this financial year.
The scheme is named after Martha Mills, who died from sepsis at the age of 13 in 2021. She had been treated at King's College Hospital, London, where a failure
to escalate her to intensive care and a lack of response to her family's concerns about her deteriorating condition contributed to her death.
Martha's Rule aims to provide a consistent and understandable way for patients and families to seek an urgent review if their or their loved one's condition
deteriorates and they are concerned this is not being responded to.
NHS England on Monday (27 May) announced that the scheme will be implemented at 143 hospital sites across the country by March 2025.
Parents are advised to check their children's hair often as cases of head lice infestations are increasing in the UK amid rising temperatures.
Superdrug has reported a significant 121 per cent surge in sales of its head lice treatment spray, according to Wales Online.
The high-street chemist explains that head lice are particularly prevalent during this time of year as the warmer weather triggers infestations.
Head lice and nits (head lice eggs) are very common in young children and are picked up by head-to-head contact. The pesky insects make your head feel itchy.
The National Health Service (NHS) recommends taking immediate action against head lice as soon as they are detected. It is not necessary to see a GP for head
lice treatment.
A Labour Party analysis of NHS trust figures has revealed that around 148,000 people died last year while waiting for treatment in England.
This is more than double the figure recorded in 2017/18, which stood at around 60,000 deaths. It even surpasses the mortality rate observed in 2021, during
the peak of the Covid pandemic.
The Labour Party obtained the data through a freedom of information request sent to every NHS trust in England. Out of the 169 acute and community trusts
contacted, 80 responded.
The total number of deaths reported by the respondents was 61,396. Extrapolating this figure to all trusts would suggest a total of 148,227 deaths.
"Raise awareness of pharmacies as places of primary health care provision," advocates the International Pharmaceutical Federation (FIP), emphasising the
need for universal recognition of pharmacists as essential healthcare professionals.
Despite significant advancements in pharmacy practice, many policymakers and members of the public still view pharmacies primarily as commercial enterprises
rather than essential providers of healthcare services.
The FIP is leading a campaign to change this perception, advocating for pharmacies to be recognised as vital components of primary health care.
Primary health care is crucial for achieving "health for all."
In 2018, the Declaration of Astana saw governments recommit to strengthening primary health care to achieve universal health coverage.
FIP, a signatory to this declaration, has since been dedicated to enhancing the role and impact of pharmacies in primary health care.
There is a state of "emergency" across the community pharmacy sector, the National Pharmacy Association (NPA) has warned.
The organisation is holding a day of protest action, called 'One Day to #SaveOurPharmacies', on 20 June to draw attention to the sector's growing crisis.
During the protest, pharmacy teams across the UK are expected to take a range of symbolic actions - such as turning the lights out for a period, asking their
staff to wear black, blacking out windows, using the day to engage with patients, inviting parliamentary candidates and using #saveourpharmacies on social
media - signifying dark times for the beleaguered community pharmacy sector, the NPA said.
The organisation decided to choose 20 June for the protest as it marks the day from which the average pharmacy across the four nations will be "lossmaking
overall."
The Pharmacists' Defence Association (PDA) has welcomed the Chancellor's announcement of a 5.5 percent pay increase for NHS pharmacists.
Following the acceptance of the NHS Pay Review Body's (PRB) recommendations, Chancellor Rachel Reeves shared the announcement in a speech to Parliament on 29 July.
She confirmed that the pay review bodies' recommendations for health and education for 2024-25 would be fully implemented.
Reeves' speech came alongside the release of her audit into public finances, a commitment she made shortly after the recent election.
The audit confirms that the recommendations from various PRBs, including those for NHS staff, doctors, dentists, teachers, and other public servants, have been
approved and will be acted upon.
"That is the right decision for the people who work in and most importantly the people who use our public services…giving hardworking staff the pay rise they
deserve while ensuring we can recruit and retain the people we need," Reeves announced.
Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy
contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector.
The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies.
Beginning August, the DHSC is set to claw back the amount.
McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies.
Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability
of many pharmacies.
"Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of their making, the Department of Health is
jeopardising the foundation of local healthcare delivery," McQuillan criticised.
Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy
contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector.
The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies.
Beginning August, the DHSC is set to claw back the amount.
McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies.
Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability
of many pharmacies.
"Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of thei
In response to concerns raised by pharmacy owners, the government has decided to adjust the August threshold for the Pharmacy First service from 20 to 15
clinical pathways.
The ability of pharmacy owners to achieve the thresholds for the monthly Pharmacy First payments has been a topic of great concern.
Community Pharmacy England (CPE) has been actively discussing this issue over the last few weeks with the Department of Health and Social Care and NHS England.
Ministers have now decided to adjust the August threshold for the Pharmacy First service to 15, CPE announced today (July 31).
Commenting on this decision, Janet Morrison, CEO of Community Pharmacy England said: "We are pleased that Ministers have listened to our concerns and acted quickly
to make an adjustment so soon after coming into office."
The UK Parliament is preparing for a significant reshuffling of select committee Chairs, a process that will shape the direction of parliamentary oversight
for the coming term.
The temporary hiatus after May 30 due to the general election on 4 July 2024, will resume as a Liberal Democrat MP will serve as the next chair of the health and
social care committee (HSCC).
Among the most critical positions up for election is the Chair of the Health and Social Care Select Committee, which has been allocated to the Liberal Democrats.
As votes are casted to select an MP and the parliamentary landscape settles, attention is turning to what this means for the future of health policy in the UK.
Liberal Dems manifesto, released during the general election that took place in July, outlined a vision for a more equitable and sustainable healthcare system,
with a focus on enhancing accessibility and patient rights.
In a delightful announcement, the University of Brighton has honoured NHS England's Chief Pharmaceutical Officer, David Webb with its prestigious Doctor
of Science honorary degree
Webb's award is a highlight of the university's graduation ceremony which celebrated the graduation of over 3,400 undergraduate and postgraduate students from 92
countries at the Brighton Centre this week.
The accolade recognises Webb's transformative work in the pharmacy services within the NHS, highlighting the profound impact his contributions have had on delivery
of healthcare across the UK.
Under Webb's leadership, significant advancements have been made in integrating pharmacy into NHS care pathways, improving patient outcomes, and enhancing the role
of pharmacists and pharmacy technicians in the healthcare system.
Webb expressed his honour stating, "I am delighted to receive the honorary award of Doctor of Science from the University of Brighton in recognition of both my
contribution to pharmacy in the NHS"
Health and Social Care Secretary, Wes Streeting, visited St Margaret's Hospital in Epping, West Essex, on Thursday (1 August) as part of an ongoing series
of planned engagements with NHS trusts across England.
Accompanied by NHS Chief Executive, Amanda Pritchard, Streeting observed how NHS staff are using innovative technology to monitor patients at home and prevent
unnecessary hospital admissions.
He met with staff from the hospital's Care Coordination Centre and the 'hospital at home' hub, which work to reduce unnecessary A&E admissions and facilitate
quick and safe discharges home.
Before the hospital tour, the health secretary met the trust's falls response team, which uses a specially equipped 'falls car' to assist patients who have
fallen at home, preventing A&E visits.
Later, Streeting visited the Ross Practice GP surgery in Harlow before holding a town hall event with health leaders in the region.
The government has accepted the Joint Committee on Vaccination and Immunisation's (JCVI) advice for the autumn 2024 COVID-19 vaccination programme.
According to the JCVI, the following groups will be eligible for vaccination this autumn:
Individuals aged 65 and over
Residents of care homes for older adults
Those aged 6 months and older in clinical risk groups
Minister for Public Health and Prevention, Andrew Gwynne, emphasised the importance of protecting vulnerable populations from COVID-19 and reducing pressure on
the NHS.
He said: "We are committed to protecting those most vulnerable from COVID and have accepted the independent advice from the JCVI for the autumn 2024 vaccination
programme."
"I encourage anyone invited for a vaccine to get one as soon as possible to protect yourself and reduce pressure on the NHS during winter, helping to cut waiting
times and get the health service back on its feet."
The Independent Pharmacies Association (IPA), in collaboration with the Association of Optometrists (AOP), the British Dental Association (BDA) and the
NHS Confederation has written to health secretary Wes Streeting, urging him to ensure sustainable investment in primary care to strengthen the NHS and better
serve patients.
In their letter, the group congratulated Streeting on his recent appointment as Secretary of State for Health and Social Care and requested a meeting to provide
their joint constructive input towards improving health outcomes.
They expressed concern that recent administrations have failed to follow through on promises to properly integrate and fund primary care, leading to deteriorating
health outcomes.
"Our collective experience is that our National Health Service (NHS), and health outcomes generally, have suffered at the hands of recent administrations that have
talked much about the importance of properly integrating and funding primary care but not followed through with action," they wrote.
The associations emphasised the need to transition the NHS to a Neighbourhood Health Service, where more care is delivered within local communities to identify
problems earlier.
Community pharmacies are being forced to halt certain NHS and public health services due to escalating financial and operational pressures, a recent survey
by Community Pharmacy England (CPE) has revealed.
In the survey conducted ahead of the June Committee Meeting, an overwhelming 96 per cent of pharmacy owners reported having stopped delivering locally
commissioned services over the past twelve months.
Additionally, nearly one-third of the pharmacies surveyed indicated they had discontinued providing some Advanced services.
The survey also revealed that pharmacy opening hours are being reduced, with 81 per cent of respondents stating they had to stop offering extended hours.
In 90 per cent of the cases, pharmacy owners had to cease employing locum pharmacists, likely due to cost constraints.
Furthermore, over 20 per cent of the more than 2,100 pharmacies surveyed reported having to discontinue the free delivery of prescription medicines to patients.
The General Pharmaceutical Council (GPHC), Royal Pharmaceutical Society (RPS), Company Chemists Association (CCA), Association of Pharmacy
Technicians UK (APTUK), National Pharmacy Association (NPA), Guild of Healthcare Pharmacists, Pharmacists' Defence Association (PDA), and Independent
Pharmacies Association (IPA) have released a joint statement in response to the far-right riots across the UK.
They emphasised their united stance, declaring zero tolerance for racism towards colleagues or the public in any form.
The joint statement reads: "We are shocked and saddened by the violent public disorder events in recent days.
"We acknowledge how all sectors of the pharmacy profession may be impacted and recognise the challenges that this level of overt aggression can have on
people's ability or willingness to live their daily lives.
"The pharmacy workforce deserves peace and safety, not fear and harm. We stand united in having a zero tolerance of racism towards our colleagues or the
public in whatever form it takes."
Meanwhile, Community Pharmacy England (CPE) has expressed concerns that protests and violent disorder in various towns and cities across England may impact
the ability of community pharmacies to operate.
The Department of Health and Social Care (DHSC) has announced adjustments to the reimbursement rates for several Aptamil products dispensed earlier this
year, following a pricing error that left pharmacies out of pocket.
The changes, which apply to products dispensed between January and April 2024, come after Community Pharmacy England (CPE) raised concerns about discrepancies
in the pricing data used by the NHS.
The issue stemmed from recent price increases by Nutricia Ltd, the manufacturer of Aptamil, which were not reflected in the NHS Dictionary of Medicines and
Devices (dm+d).
To address the shortfall, the DHSC has retrospectively increased the reimbursement prices for the following Aptamil products:
- Aptamil Anti-Reflux powder (800g): From £14.29 to £16.08
- Aptamil Comfort milk (800g): From £14.29 to £16.08
- Aptamil First milk powder (200ml): From £0.92 to £1.06
- Aptamil Follow On milk (200ml): From £0.92 to £1.06
- Aptamil Lactose Free powder (400g): From £7.70 to £8.39
These changes, effective from January 2024, are intended to ensure that pharmacies are appropriately reimbursed for the cost of these products.